Legal Representation
Attorney
Alan Taboada
USPTO Deadlines
Next Deadline
140 days remaining
NOA E-Mailed - SOU Required
Due Date
June 09, 2026
Extension Available
Until December 09, 2026
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 14, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 14, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 8, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 15, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 15, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Sep 15, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 15, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Sep 15, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jul 22, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 22, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 22, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 4, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 29, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 20, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| May 20, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 11, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the treatment of cancer
Additional Information
Design Mark
The mark consists of two interlocking "P" letters forming a link design wherein in the top half of the link is red and the bottom half is red gradually darkening to purple. To the left of the letter design is the words "PETRA PHARMA" in gray.
Color Claim
The color(s) red, purple, and gray is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"